David Conen, MD, MPH; Jorge A. Wong, MD, MPH; Roopinder K. Sandhu, MD, MPH; et al.
free access
JAMA Cardiol. 2016;1(4):389-396. doi:10.1001/jamacardio.2016.0280
This large, long-term prospective cohort study evaluates the associations between atrial fibrillation and cancer.
-
Editorial
Association of Atrial Fibrillation and Cancer
Faisal Rahman, BM, BCh; Darae Ko, MD; Emelia J. Benjamin, MD, ScM
JAMA Cardiol
Johannes Tobias Neumann, MD; Nils Arne Sörensen, MD; Tjark Schwemer, MD; et al.
free access
JAMA Cardiol. 2016;1(4):397-404. doi:10.1001/jamacardio.2016.0695
This diagnostic-test study evaluates a 1-hour diagnostic algorithm for diagnosis of acute myocardial infarction in patients presenting to the emergency department with acute chest pain.
Edward Carlton, PhD; Jaimi Greenslade, PhD; Louise Cullen, PhD; et al.
open access
has audio
JAMA Cardiol. 2016;1(4):405-412. doi:10.1001/jamacardio.2016.1309
This diagnostic-test study examines the performance of high-sensitivity troponin I concentrations measured during evaluation of patients with suspected myocardial infarction at emergency department presentation in a pooled analysis of 5 international cohort studies.
-
Podcast:
Levels of Cardiac Troponin I in Patients With Suspected Acute Coronary Syndrome (JAMA Cardiology)
Thomas H. Hauser, MD, MPH; Ninad Salastekar, MD, MPH; Ernst J. Schaefer, MD; et al.
free access
JAMA Cardiol. 2016;1(4):413-423. doi:10.1001/jamacardio.2016.0605
This randomized clinical trial determines whether targeting inflammation using salsalate compared with placebo reduces progression of noncalcified coronary artery plaque in overweight and obese statin-using patients with established, stable coronary heart disease.
Marc P. Bonaca, MD, MPH; Deepak L. Bhatt, MD, MPH; Ton Oude Ophuis, MD; et al.
free access
has audio
JAMA Cardiol. 2016;1(4):425-432. doi:10.1001/jamacardio.2016.1017
This study used data from the PEGASUS-TIMI 54 trial to investigate the reasons and timing of the discontinuation of ticagrelor among stable patients with a history of myocardial infarction.
-
Podcast:
Long-term Tolerability of Ticagrelor After Myocardial Infarction (JAMA Cardiology)
-
Editorial
Understanding the Adverse Effects of Ticagrelor in Practice
Christopher B. Granger, MD; Peter B. Berger, MD
JAMA Cardiol
Jared W. Magnani, MD, MSc; Faye L. Norby, MS; Sunil K. Agarwal, MD, PhD; et al.
free access
JAMA Cardiol. 2016;1(4):433-441. doi:10.1001/jamacardio.2016.1025
This observational cohort study evaluates the race-specific associations of atrial fibrillation with stroke, heart failure, coronary heart disease, and all-cause mortality in a community-based cohort.
Jason D. Roberts, MD, MAS; Donglei Hu, PhD; Susan R. Heckbert, MD, PhD; et al.
free access
JAMA Cardiol. 2016;1(4):442-450. doi:10.1001/jamacardio.2016.1185
This study uses data on single-nucleotide polymorphisms from cohort studies to look for genetically based racial differences in the risk for atrial fibrillation.
Ziad Hijazi, MD, PhD; Stefan H. Hohnloser, MD; Ulrika Andersson, MSc; et al.
free access
JAMA Cardiol. 2016;1(4):451-460. doi:10.1001/jamacardio.2016.1170
This study evaluates changes in renal function over time in patients with atrial fibrillation randomized to apixaban vs warfarin treatment in the ARISTOTLE randomized clinical trial.
Matthew D. Jankowich, MD; Wen-Chih Wu, MD; Gaurav Choudhary, MD
free access
JAMA Cardiol. 2016;1(4):461-469. doi:10.1001/jamacardio.2016.0962
This cohort study uses Jackson Heart Study data to investigate the association between plasma endothelin-1 levels and pulmonary hypertension and heart failure.